[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100623465":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":18,"responsibleParty":35,"collaborators":39,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":18,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":18,"enrollmentInfo":54,"targetDuration":18,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":66,"overallStatus":82,"whyStopped":18,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":18},{"fullName":5,"class":6},"University of South Florida","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Arm","EXPERIMENTAL","Participants will receive two components:\n\n1. Emergency Room (ER) staff will directly contact the asthma specialist's scheduling team to arrange a follow-up appointment within 1-3 weeks.\n2. The follow-up appointment will be conducted via telehealth (including phone calls) to assess follow-up care and asthma control of all participants.\n\nBoth Arms:\n\n• All participants will be offered a prescription for twice-daily ICS\u002FLABA (fluticasone\u002Fsalmeterol) controller therapy at ER discharge after signing informed consent. These medications are standard of care for asthma.\n\nAsthma-related surveys and study-specific questionnaires, \"medication side effects (open-ended)\" and \"follow-up care questions\" will be administered during the ER visit and again at the 3-month follow-up phone call.",[13],"Behavioral: ER-Initiated Telehealth Referral",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care Arm","NO_INTERVENTION","Participants will receive an EMR-based referral to an outpatient allergy clinic, with the option of a telehealth or in-person visit at their discretion. This referral will be offered during the 3-month follow-up phone call to ensure clinical equipoise.\n\nBoth Arms:\n\n• All participants will be offered a prescription for twice-daily ICS\u002FLABA (fluticasone\u002Fsalmeterol) controller therapy at ER discharge after signing informed consent. These medications are standard of care for asthma.\n\nAsthma-related surveys and study-specific questionnaires, \"medication side effects (open-ended)\" and \"follow-up care questions\" will be administered during the ER visit and again at the 3-month follow-up phone call.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","ER-Initiated Telehealth Referral","Participants assigned to the intervention arm will receive an asthma specialist follow up appointment that is scheduled directly from the emergency department before discharge. Emergency department staff will contact the specialist clinic to arrange a telehealth visit within 1-3 weeks. The telehealth visit will address asthma symptoms, medication use, and follow-up care needs. All participants, including those in the intervention arm, will be offered a prescription for standard inhaled corticosteroid\u002Flong-acting beta-agonist controller therapy at discharge. The intervention focuses on improving access to specialist care through proactive scheduling and telehealth delivery.",[9],[26],{"name":27,"affiliation":5,"role":28},"Juan C Cardet, MD","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Amanda McNamara, BA, LPN","CONTACT","813-396-2729","Alett1@usf.edu",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Juan Carlos Cardet","Associate Professor - Research, College of Medicine Internal Medicine",[40,42,43],{"name":41,"class":6},"Tampa General Hospital",{"name":5,"class":6},{"name":44,"class":45},"Sanofi","INDUSTRY","100623465","boosting-referrals-to-asthma-specialists-for-patients-seen-at-the-emergency-room-for-an-asthma-exacerbation-100623465",false,"NCT07396987","Boosting Referrals to Asthma Specialists for Patients Seen at the Emergency Room for an Asthma Exacerbation","Inclusion Criteria:\n\n* Age ≥18 years\n* Asthma diagnosis ≥1 year\n* Seen in ER for asthma exacerbation\n* Persistent asthma on controller therapy\n* ≥1 asthma exacerbation in prior year\n\nWe will allow for current smokers, vapers and cannabis users as long as they have not been diagnosed with COPD and have a smoking history \\\u003C10 pack-years.\n\nWe will allow for COPD as long as they are:\n\n1. never smokers\u002Fvapers\u002Fcannabis users; or\n2. former or current smokers\u002Fvapers\u002Fcannabis users with normal pulmonary function tests (PFT; FEV1\u002FFVC ratio of \\>70%) within 12 months of enrollment and a smoking history \\\u003C10 pack-years; or\n3. current or former smoker\u002Fvapers\u002Fcannabis users with obstruction on PFTs (FEV1\u002FFVC ratio of \\\u003C70%) but who demonstrate BOTH \\>10% acute bronchodilator reversibility AND a normal diffusing capacity both within 12 months of enrollment (stricter criteria than those used in the PREPARE trial (15) and a smoking history \\\u003C10 pack-years.\n\nExclusion Criteria:\n\n* Patients who have seen an asthma specialist (allergist or pulmonologist) for asthma in the past 2 years\n* Diagnosis of other pulmonary diseases (e.g., COPD, interstitial lung disease, etc.)","ALL","18 Years",{"count":55,"type":56},40,"ESTIMATED","INTERVENTIONAL",[59],"NA","This study is testing a new way to help adults with asthma get follow up care after an emergency room (ER) visit for an asthma attack. Many people who come to the ER for asthma never see an asthma specialist afterward, even though specialists can offer treatments such as advanced inhalers or biologic medicines that may prevent future attacks.\n\nThe study will compare two approaches. One group will receive a telehealth appointment with an asthma specialist that is scheduled for them before they leave the ER. The other group will receive the usual care, which typically includes a standard referral but no scheduled appointment. All participants will be offered a prescription for standard controller medication at discharge.\n\nThe main question the study aims to answer is whether arranging a telehealth visit directly from the ER increases the number of patients who complete a follow up appointment with an asthma specialist within three months. The study will also look at whether this approach improves asthma control, reduces repeat ER visits, and helps patients better understand and use their asthma medications.\n\nThis research may help identify a practical way to improve access to asthma specialists and reduce the burden of asthma for patients who frequently rely on emergency care.",[62,63,64,65],"Asthma Attack","Asthma Control","Asthma Exacerbations","Asthma",[67,68,69,70,71,72,73,74,75,76,77,78,79,80,81],"asthma","asthma exacerbation","asthma control","inhaled corticosteroid","Long-Acting Beta-Agonist","Long-Acting Muscarinic Antagonist","Emergency Room","Asthma Control Test","Medication Adherence Report Scale for Asthma","Asthma Symptom Utility Index","barriers to care","social determinants of health","access to care","telehealth","telemedicine","NOT_YET_RECRUITING","2026-05-22",{"date":85,"type":86},"2026-05-26","ACTUAL",{"date":88,"type":56},"2026-06",{"date":90,"type":56},"2027-06",{"name":37,"class":6}]